Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

B-Cell Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Morphology
Hematopoietic and Lymphoid Cell Neoplasm
Lymphocytic Neoplasm
B-Cell Neoplasm

Hematologic Malignancy

B-Cell Neoplasm

CI-CAN-00000470Explore in graph →

HematologicNon-malignant2,097 active trials46 approved drugs301 evidence items

NCIt: C27907

Overview
Statistics
Survival
Genomics29
Variants & evidence301
Drugs45
Trials7500
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (305)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 226–250 of 305 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Exploring the oncogenic and therapeutic target potential of the MYB-TYK2 fusion gene in B-cell acute lymphoblastic leukemia.
· Cancer Gene Ther · 2022 · PMID 35022522 · validated civic_curation pubmed
Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis.
· J Clin Oncol · 2009 · PMID 19636007 · validated civic_curation pubmed
Promising response of anaplastic lymphoma kinase-positive large B-cell lymphoma to crizotinib salvage treatment: case report and review of literature.
· Int J Clin Exp Med · 2015 · PMID 26221234 · validated civic_curation pubmed
Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia.
· J Clin Oncol · 2013 · PMID 23835704 · validated civic_curation pubmed
Comprehensive genomic analysis reveals FLT3 activation and a therapeutic strategy for a patient with relapsed adult B-lymphoblastic leukemia.
· Exp Hematol · 2016 · PMID 27181063 · validated civic_curation pubmed
Vemurafenib response in 2 patients with posttransplant refractory BRAF V600E-mutated multiple myeloma.
· Clin Lymphoma Myeloma Leuk · 2014 · PMID 24997557 · validated civic_curation pubmed
Extramedullary myeloma whole genome sequencing reveals novel mutations in Cereblon, proteasome subunit G2 and the glucocorticoid receptor in multi drug resistant disease.

Showing 226–250 of 305 publications

← Previous
1
…
9
10
11
12
13
Next →

· Br J Haematol · 2013 · PMID 23480694 · validated civic_curation pubmed

Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure.

· Haematologica · 2018 · PMID 29773603 · validated civic_curation pubmed

Imatinib-induced long-term remission in a relapsed RCSD1-ABL1-positive acute lymphoblastic leukemia.

· Haematologica · 2016 · PMID 27125982 · validated civic_curation pubmed

Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor alpha receptor: a new clinical target for STI571/Glivec.

· Oncogene · 2003 · PMID 12944919 · validated civic_curation pubmed

Clinical response to larotrectinib in adult Philadelphia chromosome-like ALL with cryptic ETV6-NTRK3 rearrangement.

· Blood Adv · 2020 · PMID 31905241 · validated civic_curation pubmed

High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults.

· J Clin Oncol · 2017 · PMID 27870571 · validated civic_curation pubmed

Genomic Profiling of Adult and Pediatric B-cell Acute Lymphoblastic Leukemia.

· EBioMedicine · 2016 · PMID 27428428 · validated civic_curation pubmed

Characterization of pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia with kinase fusions in Japan.

· Blood Cancer J · 2016 · PMID 27176795 · validated civic_curation pubmed

B-Cell Precursor-Acute Lymphoblastic Leukemia With EBF1-PDGFRB Fusion Treated With Hematopoietic Stem Cell Transplantation and Imatinib: A Case Report and Literature Review.

· J Pediatr Hematol Oncol · 2021 · PMID 32068648 · validated civic_curation pubmed

The t(1;9)(p34;q34) fusing ABL1 with SFPQ, a pre-mRNA processing gene, is recurrent in acute lymphoblastic leukemias.

· Leuk Res · 2011 · PMID 21388681 · validated civic_curation pubmed

SFPQ-ABL1-positive B-cell precursor acute lymphoblastic leukemias.

· Genes Chromosomes Cancer · 2020 · PMID 32306475 · validated civic_curation pubmed

t(1;9)(p34;q34)/SFPQ-ABL1 Fusion in a Patient with Ph-Like Common B-Cell Acute Lymphoblastic Leukemia.

· Acta Haematol · 2017 · PMID 27894117 · validated civic_curation pubmed

A novel dasatinib-sensitive RCSD1-ABL1 fusion transcript in chemotherapy-refractory adult pre-B lymphoblastic leukemia with t(1;9)(q24;q34).

· Haematologica · 2009 · PMID 19794096 · validated civic_curation pubmed

RCSD1-ABL1-positive B lymphoblastic leukemia is sensitive to dexamethasone and tyrosine kinase inhibitors and rapidly evolves clonally by chromosomal translocations.

· Int J Hematol · 2011 · PMID 21863287 · validated civic_curation pubmed

Acute lymphoblastic leukemia associated with RCSD1-ABL1 novel fusion gene has a distinct gene expression profile from BCR-ABL1 fusion.

· Leukemia · 2013 · PMID 23168614 · validated civic_curation pubmed

Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with RCSD1-ABL1-positive acute lymphoblastic leukemia.

· Haematologica · 2017 · PMID 28057740 · validated civic_curation pubmed

Cryptic ETV6-ABL1 Fusion and MLL2 Truncation Revealed by Integrative Clinical Sequencing in Multiply Relapsed Acute Lymphoblastic Leukemia.

· J Pediatr Hematol Oncol · 2019 · PMID 30028819 · validated civic_curation pubmed

Drug response profiling can predict response to ponatinib in a patient with t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.

· Blood Cancer J · 2015 · PMID 25768406 · validated civic_curation pubmed

Efficacy of tyrosine kinase inhibitors in Ph-like acute lymphoblastic leukemia harboring ABL-class rearrangements.

· Blood · 2019 · PMID 31434701 · validated civic_curation pubmed